Adults (18-65), Geriatrics (65+)
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
My areas of clinical expertise:
Pulmonary and Mediastinal Pathology,
Pathology - Anatomic Pathology, 2008
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Neoplastic and non-neoplastic diseases of lung, pleura and thymus.
Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ.: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA Oncology Epub ahead of print : 2019.
Walter DM, Yates TJ, Ruiz-Torres M, Kim-Kiselak C, Gudiel AA, Deshpande C, Wang WZ, Cicchini M, Stokes KL, Tobias JW, Buza E, Feldser DM.: RB constrains lineage fidelity and multiple stages of tumour progression and metastasis. Nature 569 (7756): 423-427,2019.
Predina JD, Keating J, Newton A, Corbett C, Xia L, Shin M, Frenzel Sulyok L, Deshpande C, Litzky L, Nie S, Kucharczuk JC, Singhal S.: A clinical trial of intraoperative near-infrared imaging to assess tumor extent and identify residual disease during anterior mediastinal tumor resection. Cancer 125 (5): 807-817,2019.
Predina JD, Newton A, Corbett C, Xia L, Sulyok LF, Shin M, Deshpande C, Litzky L, Barbosa E, Low PS, Kucharczuk JC, Singhal S: Localization of Pulmonary Ground-Glass Opacities with Folate Receptor-Targeted Intraoperative Molecular Imaging. J Thorac Oncol. 13 (7): 1028-1036,2018.
Jenkins TM, Morrissette JJD, Kucharczuk JC, Deshpande CG.: ROS1 Rearrangement in a Case of Classic Biphasic Pulmonary Blastoma. Int J Surg Pathol. 26 (4): 360-363,2018.
Reza N, Chowns JL, Merrill SL, Marzolf A, Zado ES, Palmer MB, Deshpande C, Pryma DA, Rame JE, Marchlinski FE, Owens AT.: Frameshifts in Code and in Care: The Importance of Timely Genetic Evaluation. Circ Genom Precis Med. 11 (5): 2018.
Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S.: An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget 9 (17): 13517-13529,2018.
Predina JD, Newton AD, Keating J, Dunbar A, Connolly C, Baldassari M, Mizelle J, Xia L, Deshpande C, Kucharczuk J, Low PS, Singhal S.: A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas. Ann Thorac Surg. 105 (3): 901-908,2018.
Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E 3rd, Stadanlick J, Kularatne SA, Low PS, Singhal S.: Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Mol Ther. 26 (2): 390-403,2018.
Predina JD, Newton A, Deshpande C, Low P, Singhal S.: Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. J Biomed Opt. 23 (1): 1-4,2018.
Department of Pathology and Laboratory Medicine3400 Spruce Street, Founders - 6.039
Phone: (215) 615-6523
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.